Phospho-ACK1 (Tyr284) Antibody - #AF7359
Product: | Phospho-ACK1 (Tyr284) Antibody |
Catalog: | AF7359 |
Description: | Rabbit polyclonal antibody to Phospho-ACK1 (Tyr284) |
Application: | WB IHC |
Reactivity: | Human, Mouse, Rat |
Prediction: | Pig, Bovine, Horse, Rabbit, Dog, Chicken, Xenopus |
Mol.Wt.: | 114kDa; 115kD(Calculated). |
Uniprot: | Q07912 |
RRID: | AB_2843799 |
Related Downloads
Protocols
Product Info
*The optimal dilutions should be determined by the end user.
*Tips:
WB: For western blot detection of denatured protein samples. IHC: For immunohistochemical detection of paraffin sections (IHC-p) or frozen sections (IHC-f) of tissue samples. IF/ICC: For immunofluorescence detection of cell samples. ELISA(peptide): For ELISA detection of antigenic peptide.
Cite Format: Affinity Biosciences Cat# AF7359, RRID:AB_2843799.
Fold/Unfold
Acetate kinase 1; Acetokinase 1; ACK 1; ACK; ACK-1; ACK1; ACK1_HUMAN; Activated Cdc42 associated kinase 1; Activated CDC42 kinase 1; Activated p21cdc42Hs kinase; FLJ44758; FLJ45547; p21cdc42Hs; TNK 2; TNK2; Tyrosine kinase non receptor 2; Tyrosine kinase non receptor protein 2; Tyrosine kinase non-receptor protein 2;
Immunogens
The Tyr-284 phosphorylated form shows a significant increase in expression in breast cancers during the progressive stages i.e. normal to hyperplasia (ADH), ductal carcinoma in situ (DCIS), invasive ductal carcinoma (IDC) and lymph node metastatic (LNMM) stages. It also shows a significant increase in expression in prostate cancers during the progressive stages.
- Q07912 ACK1_HUMAN:
- Protein BLAST With
- NCBI/
- ExPASy/
- Uniprot
MQPEEGTGWLLELLSEVQLQQYFLRLRDDLNVTRLSHFEYVKNEDLEKIGMGRPGQRRLWEAVKRRKALCKRKSWMSKVFSGKRLEAEFPPHHSQSTFRKTSPAPGGPAGEGPLQSLTCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPTDMRALQDFEEPDKLHIQMNDVITVIEGRAENYWWRGQNTRTLCVGPFPRNVVTSVAGLSAQDISQPLQNSFIHTGHGDSDPRHCWGFPDRIDELYLGNPMDPPDLLSVELSTSRPPQHLGGVKKPTYDPVSEDQDPLSSDFKRLGLRKPGLPRGLWLAKPSARVPGTKASRGSGAEVTLIDFGEEPVVPALRPCAPSLAQLAMDACSLLDETPPQSPTRALPRPLHPTPVVDWDARPLPPPPAYDDVAQDEDDFEICSINSTLVGAGVPAGPSQGQTNYAFVPEQARPPPPLEDNLFLPPQGGGKPPSSAQTAEIFQALQQECMRQLQAPAGSPAPSPSPGGDDKPQVPPRVPIPPRPTRPHVQLSPAPPGEEETSQWPGPASPPRVPPREPLSPQGSRTPSPLVPPGSSPLPPRLSSSPGKTMPTTQSFASDPKYATPQVIQAPGPRAGPCILPIVRDGKKVSSTHYYLLPERPSYLERYQRFLREAQSPEEPTPLPVPLLLPPPSTPAPAAPTATVRPMPQAALDPKANFSTNNSNPGARPPPPRATARLPQRGCPGDGPEAGRPADKIQMAMVHGVTTEECQAALQCHGWSVQRAAQYLKVEQLFGLGLRPRGECHKVLEMFDWNLEQAGCHLLGSWGPAHHKR
Predictions
Score>80(red) has high confidence and is suggested to be used for WB detection. *The prediction model is mainly based on the alignment of immunogen sequences, the results are for reference only, not as the basis of quality assurance.
High(score>80) Medium(80>score>50) Low(score<50) No confidence
PTMs - Q07912 As Substrate
Site | PTM Type | Enzyme | Source |
---|---|---|---|
T33 | Phosphorylation | Uniprot | |
S36 | Phosphorylation | Uniprot | |
Y40 | Phosphorylation | Uniprot | |
K48 | Ubiquitination | Uniprot | |
S74 | Phosphorylation | Uniprot | |
S77 | Phosphorylation | Uniprot | |
S81 | Phosphorylation | Uniprot | |
K100 | Ubiquitination | Uniprot | |
T101 | Phosphorylation | Uniprot | |
S102 | Phosphorylation | Uniprot | |
K124 | Ubiquitination | Uniprot | |
K131 | Ubiquitination | Uniprot | |
S136 | Phosphorylation | Uniprot | |
S149 | Phosphorylation | Uniprot | |
Y193 | Phosphorylation | Uniprot | |
T205 | Phosphorylation | Uniprot | |
S212 | Phosphorylation | Uniprot | |
Y284 | Phosphorylation | Q07912 (TNK2) , P12931 (SRC) | Uniprot |
T465 | Phosphorylation | Uniprot | |
K515 | Ubiquitination | Uniprot | |
T517 | Phosphorylation | Uniprot | |
Y518 | Phosphorylation | Q07912 (TNK2) | Uniprot |
K533 | Ubiquitination | Uniprot | |
T603 | Phosphorylation | Uniprot | |
S607 | Phosphorylation | Uniprot | |
Y635 | Phosphorylation | P09619 (PDGFRB) | Uniprot |
S724 | Phosphorylation | Uniprot | |
S728 | Phosphorylation | Uniprot | |
S730 | Phosphorylation | Uniprot | |
S774 | Phosphorylation | Uniprot | |
S785 | Phosphorylation | Uniprot | |
S789 | Phosphorylation | Uniprot | |
S810 | Phosphorylation | Uniprot | |
T818 | Phosphorylation | Uniprot | |
K826 | Acetylation | Uniprot | |
Y827 | Phosphorylation | Q07912 (TNK2) | Uniprot |
T829 | Phosphorylation | Uniprot | |
R839 | Methylation | Uniprot | |
S855 | Phosphorylation | Uniprot | |
S856 | Phosphorylation | Uniprot | |
T857 | Phosphorylation | Uniprot | |
Y859 | Phosphorylation | Q07912 (TNK2) , P51813 (BMX) | Uniprot |
Y860 | Phosphorylation | P51813 (BMX) | Uniprot |
S867 | Phosphorylation | Uniprot | |
Y868 | Phosphorylation | Uniprot | |
Y872 | Phosphorylation | Q07912 (TNK2) | Uniprot |
S881 | Phosphorylation | Uniprot | |
T925 | Phosphorylation | Uniprot | |
R933 | Methylation | Uniprot | |
K1011 | Ubiquitination | Uniprot | |
K1037 | Ubiquitination | Uniprot |
PTMs - Q07912 As Enzyme
Substrate | Site | Source |
---|---|---|
P10275 (AR) | Y269 | Uniprot |
P10275 (AR) | Y365 | Uniprot |
P31749 (AKT1) | Y176 | Uniprot |
P31749 (AKT1) | T308 | Uniprot |
P31749 (AKT1) | S473 | Uniprot |
P42768 (WAS) | S277 | Uniprot |
P42768 (WAS) | Y291 | Uniprot |
P56945 (BCAR1) | Y165 | Uniprot |
P56945 (BCAR1) | Y249 | Uniprot |
P56945 (BCAR1) | Y410 | Uniprot |
Q07912 (TNK2) | Y284 | Uniprot |
Q07912 (TNK2) | Y518 | Uniprot |
Q07912 (TNK2) | Y827 | Uniprot |
Q07912 (TNK2) | Y859 | Uniprot |
Q07912 (TNK2) | Y872 | Uniprot |
Q9NZC7 (WWOX) | Y287 | Uniprot |
Q9Y4C1 (KDM3A) | Y1114 | Uniprot |
Q9Y5X1 (SNX9) | Y56 | Uniprot |
Research Backgrounds
Non-receptor tyrosine-protein and serine/threonine-protein kinase that is implicated in cell spreading and migration, cell survival, cell growth and proliferation. Transduces extracellular signals to cytosolic and nuclear effectors. Phosphorylates AKT1, AR, MCF2, WASL and WWOX. Implicated in trafficking and clathrin-mediated endocytosis through binding to epidermal growth factor receptor (EGFR) and clathrin. Binds to both poly- and mono-ubiquitin and regulates ligand-induced degradation of EGFR, thereby contributing to the accumulation of EGFR at the limiting membrane of early endosomes. Downstream effector of CDC42 which mediates CDC42-dependent cell migration via phosphorylation of BCAR1. May be involved both in adult synaptic function and plasticity and in brain development. Activates AKT1 by phosphorylating it on 'Tyr-176'. Phosphorylates AR on 'Tyr-267' and 'Tyr-363' thereby promoting its recruitment to androgen-responsive enhancers (AREs). Phosphorylates WWOX on 'Tyr-287'. Phosphorylates MCF2, thereby enhancing its activity as a guanine nucleotide exchange factor (GEF) toward Rho family proteins. Contributes to the control of AXL receptor levels. Confers metastatic properties on cancer cells and promotes tumor growth by negatively regulating tumor suppressor such as WWOX and positively regulating pro-survival factors such as AKT1 and AR. Phosphorylates WASP.
Autophosphorylation regulates kinase activity. Phosphorylation on Tyr-518 is required for interaction with SRC and is observed during association with clathrin-coated pits.
Polyubiquitinated by NEDD4 and NEDD4L. Degradation can be induced by EGF and is lysosome-dependent (By similarity).
Cell membrane. Nucleus. Endosome. Cell junction>Adherens junction. Cytoplasmic vesicle membrane>Peripheral membrane protein>Cytoplasmic side. Cytoplasmic vesicle>Clathrin-coated vesicle. Membrane>Clathrin-coated pit. Cytoplasm>Perinuclear region.
Note: The Tyr-284 phosphorylated form is found both in the membrane and nucleus. Colocalizes with EGFR on endosomes. Nuclear translocation is CDC42-dependent.
The Tyr-284 phosphorylated form shows a significant increase in expression in breast cancers during the progressive stages i.e. normal to hyperplasia (ADH), ductal carcinoma in situ (DCIS), invasive ductal carcinoma (IDC) and lymph node metastatic (LNMM) stages. It also shows a significant increase in expression in prostate cancers during the progressive stages.
Interacts with NEDD4 (via WW3 domain). NEDD4L and EGF promote association with NEDD4 (By similarity). Homodimer. Interacts with AR, CDC42, WWASL and WWOX. Interacts with CSPG4 (activated). Interacts with MERTK (activated); stimulates autophosphorylation. May interact (phosphorylated) with HSP90AB1; maintains kinase activity. Interacts with NPHP1. Interacts with SNX9 (via SH3 domain). Interacts with SRC (via SH2 and SH3 domain). Interacts with EGFR, and this interaction is dependent on EGF stimulation and kinase activity of EGFR. Interacts (via kinase domain) with AKT1. Part of a collagen stimulated complex involved in cell migration composed of CDC42, CRK, TNK2 and BCAR1/p130cas. Interacts with BCAR1/p130cas via SH3 domains. Forms complexes with GRB2 and numerous receptor tyrosine kinases (RTK) including LTK, AXL or PDGFRL, in which GRB2 promotes RTK recruitment by TNK2.
The EBD (EGFR-binding domain) domain is necessary for interaction with EGFR.
The SAM-like domain is necessary for NEDD4-mediated ubiquitination. Promotes membrane localization and dimerization to allow for autophosphorylation.
The UBA domain binds both poly- and mono-ubiquitin.
Belongs to the protein kinase superfamily. Tyr protein kinase family.
Restrictive clause
Affinity Biosciences tests all products strictly. Citations are provided as a resource for additional applications that have not been validated by Affinity Biosciences. Please choose the appropriate format for each application and consult Materials and Methods sections for additional details about the use of any product in these publications.
For Research Use Only.
Not for use in diagnostic or therapeutic procedures. Not for resale. Not for distribution without written consent. Affinity Biosciences will not be held responsible for patent infringement or other violations that may occur with the use of our products. Affinity Biosciences, Affinity Biosciences Logo and all other trademarks are the property of Affinity Biosciences LTD.